Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew C Cheung

Showing results (51-60 of 147) with videos related to

Pageof 15
Sort By:
British Journal of Haematology|April 19, 2020
Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjectsLiam Smyth, Danielle N Blunt, Evgenia Gatov, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2021
Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based RegistryDanielle N Blunt, Liam Smyth, Chenthila Nagamuthu, et al.
BMJ Open|August 11, 2023
Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunitiesBrooke E Wilson, Annette E Hay, Kelvin Kar-Wing Chan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2020
Quantifying the Survival Benefits of Oncology Drugs With a Focus on Immunotherapy Using Restricted Mean Survival TimeAmanda Putri Rahmadian, Seanthel Delos Santos, Shruti Parshad, et al.
JNCI Cancer Spectrum|July 31, 2019
Reliability of Oncology Value Framework Outputs: Concordance Between Independent Research GroupsJoseph C Del Paggio, Sierra Cheng, Christopher M Booth, et al.
Leukemia & Lymphoma|June 3, 2014
Shelf-life extension of azacitidine: waste and cost reduction in the treatment of myelodysplastic syndromesHany R Guirguis, Lauren F Charbonneau, Ivan Tyono, et al.
Scientific Reports|December 4, 2020
Predictors of intensive care unit admission in patients with hematologic malignancyAbi Vijenthira, Nicholas Chiu, Daniel Jacobson, et al.
Blood Neoplasia|April 17, 2026
Outcomes of transplant-eligible and transplant-ineligible patients with mantle cell lymphoma in OntarioAdam Suleman, Zharmaine Ante, Ning Liu, et al.
Leukemia & Lymphoma|June 14, 2011
High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphomaLauren M Gerard, Kevin R Imrie, Joy Mangel, et al.
Leukemia & Lymphoma|January 24, 2024
The impact of marginalization on diffuse large B-cell lymphoma overall survival: a retrospective cohort studySumedha Arya, Lee Mozessohn, Inna Gong, et al.
Pageof 15

Showing results (51-60 of 147) with videos related to

Sort By:
Pageof 15
British Journal of Haematology|April 19, 2020
Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjectsLiam Smyth, Danielle N Blunt, Evgenia Gatov, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2021
Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based RegistryDanielle N Blunt, Liam Smyth, Chenthila Nagamuthu, et al.
BMJ Open|August 11, 2023
Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunitiesBrooke E Wilson, Annette E Hay, Kelvin Kar-Wing Chan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2020
Quantifying the Survival Benefits of Oncology Drugs With a Focus on Immunotherapy Using Restricted Mean Survival TimeAmanda Putri Rahmadian, Seanthel Delos Santos, Shruti Parshad, et al.
JNCI Cancer Spectrum|July 31, 2019
Reliability of Oncology Value Framework Outputs: Concordance Between Independent Research GroupsJoseph C Del Paggio, Sierra Cheng, Christopher M Booth, et al.
Leukemia & Lymphoma|June 3, 2014
Shelf-life extension of azacitidine: waste and cost reduction in the treatment of myelodysplastic syndromesHany R Guirguis, Lauren F Charbonneau, Ivan Tyono, et al.
Scientific Reports|December 4, 2020
Predictors of intensive care unit admission in patients with hematologic malignancyAbi Vijenthira, Nicholas Chiu, Daniel Jacobson, et al.
Blood Neoplasia|April 17, 2026
Outcomes of transplant-eligible and transplant-ineligible patients with mantle cell lymphoma in OntarioAdam Suleman, Zharmaine Ante, Ning Liu, et al.
Leukemia & Lymphoma|June 14, 2011
High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphomaLauren M Gerard, Kevin R Imrie, Joy Mangel, et al.
Leukemia & Lymphoma|January 24, 2024
The impact of marginalization on diffuse large B-cell lymphoma overall survival: a retrospective cohort studySumedha Arya, Lee Mozessohn, Inna Gong, et al.
Pageof 15